Zdrowie i gospodarka · 15/08/2012
FDA Releases Draft Guidance on Suicidal Ideation in Clinical Trials
The FDA has made available a draft guidance to help pharmaceutical companies assess the risk of suicidal thoughts and behaviors in clinical trials, replacing a previous version issued in 2010.